CohBar Inc (CWBR)
OTHER OTC:CWBR
US Market
Holding CWBR?
Track your performance easily

CohBar (CWBR) Stock Price & Analysis

569 Followers

CWBR Stock Chart & Stats


Financials

Annual

Ownership Overview

6.24%93.76%
Insiders
Mutual Funds
6.24% Other Institutional Investors
93.76% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CWBR FAQ

What was CohBar Inc’s price range in the past 12 months?
CohBar Inc lowest stock price was <$0.01 and its highest was $1.39 in the past 12 months.
    What is CohBar Inc’s market cap?
    Currently, no data Available
    When is CohBar Inc’s upcoming earnings report date?
    CohBar Inc’s upcoming earnings report date is Aug 12, 2024 which is 80 days ago.
      How were CohBar Inc’s earnings last quarter?
      Currently, no data Available
      Is CohBar Inc overvalued?
      According to Wall Street analysts CohBar Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does CohBar Inc pay dividends?
        CohBar Inc does not currently pay dividends.
        What is CohBar Inc’s EPS estimate?
        CohBar Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does CohBar Inc have?
        CohBar Inc has 2,906,926 shares outstanding.
          What happened to CohBar Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of CohBar Inc?
          Currently, no hedge funds are holding shares in CWBR
          ---

          CohBar Stock Smart Score

          Company Description

          CohBar Inc

          CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.
          ---

          CWBR Earnings Call

          Q3 2022
          0:00 / 0:00
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Capricor Therapeutics
          Cyclacel Pharmaceuticals
          Eloxx Pharmaceuticals
          Moleculin Biotech
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis